3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Mb02: new trials by email Literature Review of Mb02 trials Research Report on Mb02
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Bevacizumab, Laboratory Biomarker Analysis, Letrozole - Invasive Breast Carcinoma, Recurrent Breast Carcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 394 | 2008-09-24 | 2026-08-28 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Bevacizumab, Cisplatin, Docetaxel - Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Phase 3 | Completed | National Cancer Institute (NCI) | 1501 | 2007-07-19 | 2026-06-23 |
| Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Bevacizumab, Fluorouracil, Leucovorin - Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7 | Phase 3 | Completed | National Cancer Institute (NCI) | 2431 | 2005-09-06 | 2026-08-25 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1)
National Cancer Institute (NCI) (3)
United States (3) · Canada (2) · Peru (2) · Puerto Rico (2) · South Africa (2) · Ireland (1)
Al B Benson (1) · Heather A Wakelee (1) · Hope S Rugo (1)
PMID 27138575, PMID 29129443, PMID 29789969, PMID 31276981, PMID 34616010, PMID 41666849
U10CA021115 (2), U10CA180820 (2), U10CA031946 (1), U10CA180821 (1)